Quantification of apolipoprotein C-III in serum by a noncompetitive immunoenzymometric assay
- PMID: 3899407
Quantification of apolipoprotein C-III in serum by a noncompetitive immunoenzymometric assay
Abstract
We used a noncompetitive immunoenzymometric assay to measure the concentration of total apolipoprotein C-III in human sera. Affinity-purified antibodies to apolipoprotein C-III were adsorbed to the surface of microtiter plates. After washing, this solid-phase antibody was incubated with antigen (serum from fasting subjects), washed, and then incubated with peroxidase-labeled purified antibodies to apolipoprotein C-III. After a last washing, the bound label was assayed, providing a direct measurement of the antigen. Optimized technical conditions for the assay yielded assay CVs of 3.5 and 5.6% for within- and between-run precision, respectively. Analytical recovery of apolipoprotein C-III added to a serum was quantitative (97%). This noncompetitive assay can be used to measure apolipoprotein C-III in different lipoprotein fractions (very-low or high-density fractions) and yields values that compare favorably with those obtained by electroimmunoassay (r = 0.94). The assay offers several advantages over existing techniques--sensitivity, specificity, simplicity, and no use of radioisotopes--and hyperlipemic samples can be used.
Similar articles
-
Noncompetitive enzyme-linked immunoassay for apolipoprotein B in serum.Clin Chem. 1984 Jan;30(1):98-100. Clin Chem. 1984. PMID: 6360423
-
Enzyme immunoassay for human apolipoprotein B, the major protein moiety in low-density- and very-low-density lipoproteins.Clin Chem. 1978 Mar;24(3):455-9. Clin Chem. 1978. PMID: 204430
-
Antibodies of predetermined specificity to apolipoprotein C-II elicited with a synthetic peptide. Characterization and use for immunoassays.J Immunol Methods. 1988 Apr 22;109(1):61-8. doi: 10.1016/0022-1759(88)90442-5. J Immunol Methods. 1988. PMID: 2451696
-
Recent progress in the development of radioimmunoassays for human serum lipoproteins.Ann Clin Lab Sci. 1978 Mar-Apr;8(2):142-54. Ann Clin Lab Sci. 1978. PMID: 205163 Review.
-
Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.Ann Biol Clin (Paris). 1989;47(8):497-501. Ann Biol Clin (Paris). 1989. PMID: 2690681 Review.
Cited by
-
Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.J Clin Invest. 1995 Feb;95(2):705-12. doi: 10.1172/JCI117717. J Clin Invest. 1995. PMID: 7860752 Free PMC article.
-
Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.J Clin Invest. 1998 Aug 1;102(3):625-32. doi: 10.1172/JCI1581. J Clin Invest. 1998. PMID: 9691099 Free PMC article. Clinical Trial.
-
Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group.Br J Clin Pharmacol. 1994 Sep;38(3):257-63. doi: 10.1111/j.1365-2125.1994.tb04350.x. Br J Clin Pharmacol. 1994. PMID: 7826828 Free PMC article. Clinical Trial.